non-glp-1 medications The Impact of GLP-1 Receptor Agonists on Sedation GLP-1 Medications Infographic | Medidex

Mounjaro is a GLP-1 receptor agonist and mimics glucose-dependent insulinotropic polypeptide (GIP), which is a hormone that helps release food after eating

Nutritional Deficiencies The mechanism that makes GLP-1 medications effective, slowing digestion and reducing food intake, can also lead to significant nutritional gaps: Many patients consume fewer calories, making it difficult to obtain adequate nutrients Altered digestive processes may reduce the efficiency of nutrient absorption Key nutrients at risk include calcium, vitamin D, B vitamins, iron, and protein 4

Its understandable

Identification and validation of a PD-L1 binding peptide for determination of PDL1 expression in tumors

USA 87 , 71857189 (1990)